Target intelligence / Profile preview

Peroxisomal biogenesis factor 1 (PEX1)

Target
PEX1
Molecular classification
Enzyme, AAA-ATPase, Peroxin, Other
01

Overview

Peroxisomal biogenesis factor 1 (PEX1) is an ATPase of the AAA protein family, functioning as a peroxin essential for the formation, maintenance, and protein import machinery of peroxisomes[1][3][5][7]. PEX1, in complex with PEX6, forms a heterohexameric AAA-ATPase that uses ATP-driven conformational changes to extract the peroxisomal import receptor PEX5 from the peroxisomal membrane, thus recycling it for further rounds of matrix enzyme import[5][6][7]. Mutations in PEX1 disrupt peroxisome assembly and function, and are the leading genetic cause of Zellweger spectrum disorders, including Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease[1][2][3][5]. These diseases present as devastating, multisystem, usually lethal pediatric disorders caused by failure of peroxisome biogenesis and resultant defects in lipid metabolism and detoxification pathways[1][2][5][7]. No approved drugs directly target PEX1; current medical interest is genetic and diagnostic, not pharmacologic.

Other names
Peroxisomal ATPase PEX1Peroxin-1Peroxisome biogenesis disorder protein 1HMLR1PBD1APBD1BZWSZWS1
02

Biological functions

Peroxisome biogenesisPeroxisome maintenanceProtein import into peroxisomeOrganelle turnover
03

Disease associations

Neurodegenerative diseasePeroxisome biogenesis disorderZellweger spectrum disordersNeonatal adrenoleukodystrophyInfantile Refsum disease
04

Safety considerations

Mutations in PEX1 are the most common genetic cause of Zellweger spectrum disorder, a lethal inherited peroxisomal biogenesis disease.

Beyond the preview

Go deeper on Peroxisomal biogenesis factor 1 (PEX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peroxisomal biogenesis factor 1 (PEX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call